Nobivac®

Canine 1-Pv

A proven method for protecting dogs against all strains of canine parvovirus.

CANINE 1-PV PROVDIDED PROTECTION AGAINST CPV

Canine Parvovirus (modified live virus).

  • Protects against all known CPV strains, including CPV-2c2,3
    • Contains CPV-2b, one of the most prevalent field strains of parvovirus
  • First to publish data showing protection against CPV-2c challenge2
  • Study showed no clinical signs of infection in vaccinated puppies after challenge with mixed CPV-2b and CPV-2c strains2
  • High antigenic mass (titer), low passage vaccine protects against all field strains currently seen
  • Multiple studies demonstrate the ability to override maternal antibodies1

INDICATIONS:

Approved for the vaccination of healthy dogs as an aid in the prevention of disease caused by canine parvovirus.

Recommended for use in healthy dogs 6 weeks of age or older.

EFFICACY & COMPARISONS

Nobivac® vaccines have been demonstrated in multiple studies to override maternal antibodies.1

  • Demonstrated to induce 100% seroconversion to CPV after the first round of vaccination at 6 weeks of age1

Maternal antibodies can interfere with vaccination

  • Interfering maternally derived antibodies are a primary cause of vaccine failure9
  • Puppies may be susceptible if the level of antibodies to CPV is sufficient to cause failure but insufficient to provide protection9
  • A vaccine that does not override maternal antibodies can make vaccination scheduling difficult9

ADMINISTRATION AND DOSAGE

  • Subcutaneous or intramuscular injection
  • Two 1 mL doses given 2 to 4 weeks apart
  • Repeat at 2 to 4 week intervals until the dog is 12 weeks of age
  • Annual revaccination with 1 dose is recommended
  • Available in a 25 x 1 mL dose presentation

DISEASE INFORMATION

Professional Resources and Educational Materials

Keep your clinic and staff informed and aware of diseases and outbreaks.

AAHA Canine Vaccination Guidelines

In-depth information about canine vaccinations and veterinary best practices.

Download

Nobivac® Social Media Kits

Digital Assets

Use these ready-to-share posts to educate pet parents and drive business to your clinic for preventative care.

Download

Quick Guide to Lepto

eBook

A handy guide to protect dogs and prevent the spread of leptospirosis.

Download

No items to show.

Loading…

References:

1. Data on file, Merck Animal Health. 

2. Larson LJ, Schultz RD. Do two current canine parvovirus type 2 and 2b vaccines provide protection against the new type 2c variant? Vet Ther. 2008;9(2):94–101. 

3. Schultz RD, Thiel B, Mukhtar E, Sharp P, Larson LJ. Age and long-term protective immunity in dogs and cats. J Comp Pathol. 2010;142 Suppl 1:S102–S108. 

9. Greene CE, Decaro N. Canine viral enteritis. In: Greene CE, ed. Infectious Diseases of the Dog and Cat. 4th ed. St. Louis, MO: Saunders/Elsevier; 2012:67-80.

View All Nobivac References